No Data
No Data
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (NASDAQ:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff
JMP Securities Maintains Generation Bio(GBIO.US) With Hold Rating
JMP Securities analyst Silvan Tuerkcan maintains $Generation Bio(GBIO.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 36.4% and a total average return of 4.1% ove
Analysts' Opinions Are Mixed on These Healthcare Stocks: Generation Bio (GBIO), LAVA Therapeutics (LVTX) and Aura Biosciences Inc (AURA)
Generation Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Sales Results.
Generation Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Sales Results.
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersDelcath Systems (NASDAQ:DCTH) stock rose 33.2% to $7.19 during Tuesday's regular session. The company's market cap stands at $199.8 million. As per the news, the Q1 earnings report came out tod
Generation Bio Price Target Maintained With a $10.00/Share by Needham
Generation Bio Price Target Maintained With a $10.00/Share by Needham
No Data